vs
Side-by-side financial comparison of AerSale Corp (ASLE) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $90.9M, roughly 1.7× AerSale Corp). Nutex Health, Inc. runs the higher net margin — 7.8% vs 5.9%, a 1.9% gap on every dollar of revenue. On growth, AerSale Corp posted the faster year-over-year revenue change (-4.0% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $9.8M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 0.2%).
AerSale, Inc. is a Doral, Florida-based global supplier of aftermarket commercial jet aircraft, engines, used materials, and aeronautical engineering services to passenger and cargo airlines, government, multinational original equipment manufacturers, and independent MROs. AerSale is a member of the Aircraft Fleet Recycling Association.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
ASLE vs NUTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $90.9M | $151.7M |
| Net Profit | $5.4M | $11.8M |
| Gross Margin | 34.1% | 30.4% |
| Operating Margin | 7.8% | 20.4% |
| Net Margin | 5.9% | 7.8% |
| Revenue YoY | -4.0% | -41.1% |
| Net Profit YoY | 99.7% | -80.8% |
| EPS (diluted) | $0.10 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $90.9M | $151.7M | ||
| Q3 25 | $71.2M | $267.8M | ||
| Q2 25 | $107.4M | $244.0M | ||
| Q1 25 | $65.8M | $211.8M | ||
| Q4 24 | $94.7M | $257.6M | ||
| Q3 24 | $82.7M | $78.8M | ||
| Q2 24 | $77.1M | $76.1M | ||
| Q1 24 | $90.5M | $67.5M |
| Q4 25 | $5.4M | $11.8M | ||
| Q3 25 | $-120.0K | $55.4M | ||
| Q2 25 | $8.6M | $-17.7M | ||
| Q1 25 | $-5.3M | $21.2M | ||
| Q4 24 | $2.7M | $61.6M | ||
| Q3 24 | $509.0K | $-8.8M | ||
| Q2 24 | $-3.6M | $-364.0K | ||
| Q1 24 | $6.3M | $-364.0K |
| Q4 25 | 34.1% | 30.4% | ||
| Q3 25 | 30.2% | 57.8% | ||
| Q2 25 | 32.9% | 51.2% | ||
| Q1 25 | 27.3% | 55.9% | ||
| Q4 24 | 31.4% | 55.0% | ||
| Q3 24 | 28.6% | 27.8% | ||
| Q2 24 | 28.2% | 29.7% | ||
| Q1 24 | 31.8% | 15.1% |
| Q4 25 | 7.8% | 20.4% | ||
| Q3 25 | 4.0% | 48.7% | ||
| Q2 25 | 11.7% | 13.8% | ||
| Q1 25 | -10.1% | 38.1% | ||
| Q4 24 | 5.2% | 44.4% | ||
| Q3 24 | 2.4% | 12.3% | ||
| Q2 24 | -2.4% | 7.0% | ||
| Q1 24 | 5.2% | 2.1% |
| Q4 25 | 5.9% | 7.8% | ||
| Q3 25 | -0.2% | 20.7% | ||
| Q2 25 | 8.0% | -7.3% | ||
| Q1 25 | -8.0% | 10.0% | ||
| Q4 24 | 2.9% | 23.9% | ||
| Q3 24 | 0.6% | -11.2% | ||
| Q2 24 | -4.7% | -0.5% | ||
| Q1 24 | 6.9% | -0.5% |
| Q4 25 | $0.10 | $2.34 | ||
| Q3 25 | $0.00 | $7.76 | ||
| Q2 25 | $0.18 | $-2.95 | ||
| Q1 25 | $-0.10 | $3.33 | ||
| Q4 24 | $0.05 | $11.56 | ||
| Q3 24 | $0.01 | $-1.72 | ||
| Q2 24 | $-0.07 | $-0.07 | ||
| Q1 24 | $0.12 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.4M | $185.6M |
| Total DebtLower is stronger | $1.3M | — |
| Stockholders' EquityBook value | $424.4M | $329.4M |
| Total Assets | $640.5M | $918.5M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $185.6M | ||
| Q3 25 | $5.3M | $166.0M | ||
| Q2 25 | $5.7M | $96.7M | ||
| Q1 25 | $4.7M | $84.7M | ||
| Q4 24 | $4.7M | $40.6M | ||
| Q3 24 | $9.8M | $46.9M | ||
| Q2 24 | $4.3M | $40.8M | ||
| Q1 24 | $2.6M | $30.0M |
| Q4 25 | $1.3M | — | ||
| Q3 25 | $1.5M | — | ||
| Q2 25 | $907.0K | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $376.0K | — | ||
| Q2 24 | $522.0K | — | ||
| Q1 24 | $3.5M | — |
| Q4 25 | $424.4M | $329.4M | ||
| Q3 25 | $417.1M | $317.2M | ||
| Q2 25 | $415.9M | $235.3M | ||
| Q1 25 | $406.5M | $176.9M | ||
| Q4 24 | $455.6M | $132.4M | ||
| Q3 24 | $451.5M | $60.4M | ||
| Q2 24 | $449.8M | $62.7M | ||
| Q1 24 | $452.0M | $63.0M |
| Q4 25 | $640.5M | $918.5M | ||
| Q3 25 | $646.3M | $964.5M | ||
| Q2 25 | $646.7M | $841.0M | ||
| Q1 25 | $646.1M | $761.9M | ||
| Q4 24 | $604.7M | $655.3M | ||
| Q3 24 | $601.5M | $438.5M | ||
| Q2 24 | $598.7M | $422.4M | ||
| Q1 24 | $571.7M | $404.3M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.4M | $70.4M |
| Free Cash FlowOCF − Capex | $9.8M | $69.0M |
| FCF MarginFCF / Revenue | 10.8% | 45.5% |
| Capex IntensityCapex / Revenue | 1.7% | 0.9% |
| Cash ConversionOCF / Net Profit | 2.11× | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | $-29.1M | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.4M | $70.4M | ||
| Q3 25 | $-8.9M | $99.5M | ||
| Q2 25 | $19.8M | $27.3M | ||
| Q1 25 | $-45.2M | $51.0M | ||
| Q4 24 | $37.5M | $54.0K | ||
| Q3 24 | $10.4M | $6.8M | ||
| Q2 24 | $-15.3M | $13.3M | ||
| Q1 24 | $-21.5M | $3.1M |
| Q4 25 | $9.8M | $69.0M | ||
| Q3 25 | $-9.8M | $99.2M | ||
| Q2 25 | $18.6M | $26.5M | ||
| Q1 25 | $-47.6M | $50.9M | ||
| Q4 24 | $32.3M | $-341.0K | ||
| Q3 24 | $8.9M | $6.2M | ||
| Q2 24 | $-18.9M | $12.7M | ||
| Q1 24 | $-25.0M | $2.3M |
| Q4 25 | 10.8% | 45.5% | ||
| Q3 25 | -13.8% | 37.0% | ||
| Q2 25 | 17.3% | 10.9% | ||
| Q1 25 | -72.4% | 24.0% | ||
| Q4 24 | 34.0% | -0.1% | ||
| Q3 24 | 10.7% | 7.8% | ||
| Q2 24 | -24.6% | 16.7% | ||
| Q1 24 | -27.7% | 3.4% |
| Q4 25 | 1.7% | 0.9% | ||
| Q3 25 | 1.3% | 0.1% | ||
| Q2 25 | 1.1% | 0.3% | ||
| Q1 25 | 3.7% | 0.0% | ||
| Q4 24 | 5.6% | 0.2% | ||
| Q3 24 | 1.9% | 0.8% | ||
| Q2 24 | 4.7% | 0.7% | ||
| Q1 24 | 3.9% | 1.1% |
| Q4 25 | 2.11× | 5.95× | ||
| Q3 25 | — | 1.80× | ||
| Q2 25 | 2.31× | — | ||
| Q1 25 | — | 2.40× | ||
| Q4 24 | 13.89× | 0.00× | ||
| Q3 24 | 20.52× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -3.42× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASLE
| Products | $57.8M | 64% |
| Maintenance | $23.2M | 26% |
| Leasing Arrangements | $9.9M | 11% |
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
